Immunohistochemical results in nodal peripheral T cell lymphomas (PTCLs) and other lymphoid lesions I
| Lesion | n | CD10 | BCL6 | PD-1 | CXCL13 | ||||||||||||||||
| − | + | ++ | +++ | % | − | + | ++ | +++ | % | − | + | ++ | +++ | % | − | + | ++ | +++ | % | ||
| AITL | 48 | 12 | 12 | 11 | 13 | 75.0 | 16 | 10 | 12 | 10 | 66.7 | 3 | 8 | 11 | 26 | 93.8 | 1 | 7 | 16 | 24 | 97.9 |
| PTCL, NOS | 81 | 73 | 4 | 2 | 2 | 9.9 | 74 | 2 | 3 | 2 | 8.6 | 67 | 5 | 5 | 4 | 17.3 | 64 | 7 | 5 | 5 | 21.0 |
| ALCL, ALK− | 14 | 14 | 0 | 0 | 0 | 0.0 | 10 | 1 | 2 | 1 | 28.6 | 13 | 0 | 1 | 0 | 7.1 | 13 | 0 | 1 | 0 | 7.1 |
| ALCL, ALK+ | 19 | 19 | 0 | 0 | 0 | 0.0 | 6 | 0 | 3 | 10 | 68.4 | 19 | 0 | 0 | 0 | 0.0 | 19 | 0 | 0 | 0 | 0.0 |
| NKTCL | 11 | 11 | 0 | 0 | 0 | 0.0 | 8 | 0 | 0 | 3 | 27.3 | 11 | 0 | 0 | 0 | 0.0 | 5 | 0 | 0 | 6 | 54.5 |
| T-LBL | 11 | 8 | 0 | 0 | 3 | 27.3 | 10 | 0 | 1 | 0 | 9.1 | 11 | 0 | 0 | 0 | 0.0 | 11 | 0 | 0 | 0 | 0.0 |
AITL, angioimmunoblastic T cell lymphoma; ALCL, ALK−, anaplastic large cell lymphoma, anaplastic lymphoma kinase-negative; ALCL, ALK+, anaplastic large cell lymphoma, ALK-positive; NKTCL, NK/T cell lymphoma; PD-1, programmed death-1; PTCL,NOS, peripheral T cell lymphoma, not otherwise specified; T-LBL, T lymphoblastic lymphoma.